Trade

Amrutanjan Health Care share price

Balanced risk
  • 25%Low risk
  • 25%Moderate risk
  • 25%Balanced risk
  • 25%High risk
  • 25%Extreme risk
  • 610.80(0.07%)
    January 13, 2026 09:30:48 AM IST
    • NSE
    • BSE
  • Vol : 0.33 K (NSE + BSE)
    Last 20 day avg : 18.08 K

Amrutanjan Health Care is trading 0.07% upper at Rs 610.80 as compared to its last closing price. Amrutanjan Health Care has been trading in the price range of 612.70 & 610.80. Amrutanjan Health Care has given -8.63% in this year & -7.61% in the last 5 days. Amrutanjan Health Care has TTM P/E ratio 36.38 as compared to the sector P/E of 23.01.The company posted a net profit of 13.96 Crores in its last quarter.Listed peers of Amrutanjan Health Care include Dr Reddy's Laboratories (-1.47%), Sun Pharmaceutical Industries (-0.70%), Cipla (-1.30%).The Mutual Fund holding in Amrutanjan Health Care was at 7.55% in 30 Sep 2025. The MF holding has decreased from the last quarter. The FII holding in Amrutanjan Health Care was at 2.38% in 30 Sep 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Jan 13, 2026, 04:10 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.87
    Medium volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.01
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.58
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -3.73
    Indicates undervaluation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
Price range
Day Range
Lowest
610.80
Highest
612.70
52 week range
Lowest
548.05
Highest
829.00
Amrutanjan Health Care Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Dr Reddy's Laboratories
Bearish
1,197.80-1.471,00,000.2518.633.140.632.34
Sun Pharmaceutical Industries
Neutral
1,724.75-0.704,14,400.1136.245.770.920.50
Cipla
Bearish
1,447.00-1.301,16,884.5722.953.870.870.81
Torrent Pharmaceuticals
Bullish
3,914.15-0.861,32,467.3067.3217.10.8317.62
Divi's Laboratories
Neutral
6,428.70-0.921,70,571.0978.6111.520.460.01
Mutual Fund Ownership
View all
ICICI Prudential FMCG Fund Growth
NA
  • Amount Invested (Cr.) 50.82
  • % of AUM 2.51
DSP Small Cap Fund Regular Plan Growth
3/5
  • Amount Invested (Cr.) 104.40
  • % of AUM 0.64
Amrutanjan Health Care Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2025-11-10Quarterly Results & Interim Dividend
2025-08-12Quarterly Results
2025-05-15Audited Results & Final Dividend
2025-02-12Quarterly Results & Interim Dividend
2024-11-12Quarterly Results & Interim Dividend
About the company Amrutanjan Health Care
  • IndustryBiotechnology & Drugs
  • ISININE098F01031
  • BSE Code590006
  • NSE CodeAMRUTANJAN
Amrutanjan Health Care Limited is an India-based company, which is engaged in the business of manufacturing, supplying and sale of products in pain management, congestion management, beverages, and hygiene and services in pain management. Its segments include OTC Products, Women Hygiene, Beverages and Others. The OTC Products segment is engaged in manufacturing products for pain management, congestion management and hygiene. The Women Hygiene includes Comfy Snug Fit, Comfy Snug Fit Extra Long, and Comfy Snug Fit Ultra XL. The Beverages segment is engaged in manufacturing fruit juices and oral hydration drinks. The Others segment includes the pain management center. The Company’s pain management products include Pain Balm Extra Power, Strong Pain Balm, New Maha Strong Pain Balm, Roll on and Advanced Back Pain + Roll-On, among others. Its congestion management products include Relief Cold Rub, Relief Nasal Inhaler, Relief Cough Syrup and Relief Swas Mint.
  • Management Info
  • Sambhu SivalenkaExecutive Chairman of the Board, Managing Director
  • N. SwaminathanChief Financial Officer
  • Mani BhagavatheeswaranChief Marketing Officer
  • Gagan SinghGeneral Manager - Legal, Company Secretary & Compliance Officer
  • S. JeyakanthChief Operating Officer - Supply Chain and Product Delivery
  • Soumomoy PalAssociate Vice President - Information Technology
  • J. RavichandranAssociate Vice President - QC/ QA/ R&D
Amrutanjan Health Care Share Price FAQs

Amrutanjan Health Care is trading at 610.80 as on Tue Jan 13 2026 04:00:48. This is 0.07% upper as compared to its previous closing price of 610.35.

The market capitalization of Amrutanjan Health Care is 1773.35 Cr as on Tue Jan 13 2026 04:00:48.

The 52 wk high for Amrutanjan Health Care is 829.00 whereas the 52 wk low is 548.05

Amrutanjan Health Care can be analyzed on the following key metrics -

  • TTM P/E: 36.38
  • Sector P/E: 23.01
  • Dividend Yield: 0.59%
  • D/E ratio: 0.01

Amrutanjan Health Care reported a net profit of 50.83 Cr in 2025.

The Mutual Fund Shareholding was 7.55% at the end of 30 Sep 2025.